Earnings Per Share - Narrative (Details) - USD ($) shares in Millions |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 01, 2023 |
Oct. 29, 2023 |
Oct. 30, 2022 |
Oct. 29, 2023 |
Oct. 30, 2022 |
Mar. 23, 2022 |
Oct. 01, 2021 |
Sep. 30, 2021 |
Dec. 01, 2020 |
Nov. 30, 2020 |
Jan. 31, 2019 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||||||||
| Anti-dilutive stock options (in shares) | 0.1 | 0.1 | |||||||||
| Aggregate amount authorized for stock repurchase (up to) | $ 1,000,000,000 | $ 641,200,000 | $ 141,200,000 | $ 500,000,000 | $ 263,600,000 | $ 500,000,000 | |||||
| Remaining authorized repurchase amount | $ 243,200,000 | $ 243,200,000 | |||||||||
| Repurchase of common stock (in shares) | 1.4 | 1.2 | |||||||||
| Repurchase of common stock | $ 212,626,000 | $ 16,992,000 | $ 504,643,000 | $ 374,976,000 | |||||||
| Subsequent Event | |||||||||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||||||||
| Repurchase of common stock (in shares) | 0.1 | ||||||||||
| Repurchase of common stock | $ 20,400,000 | ||||||||||